Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,797,590 | 11,657,940 | 10,729,790 | 10,563,350 | 10,583,210 |
| Marketable Securities | 5,183,721 | 4,276,525 | 4,134,882 | 7,598,182 | 7,790,336 |
| Receivables | 906,599 | 1,632,418 | 1,071,409 | 1,638,191 | 1,317,321 |
| Inventories | 263,821 | 261,891 | 268,010 | 306,559 | 333,289 |
| Other current assets | 352,779 | 253,936 | 257,369 | 240,988 | 303,274 |
| TOTAL | $18,504,510 | $18,082,710 | $16,461,460 | $20,347,270 | $20,327,430 |
| Non-Current Assets | |||||
| PPE Net | 1,215,305 | 1,155,407 | 1,080,996 | 1,012,088 | 1,008,773 |
| Investments And Advances | 2,894,196 | 2,843,449 | 2,408,090 | 1,356,953 | 1,464,887 |
| Intangibles | 2,042,653 | 2,101,368 | 1,988,060 | 1,267,139 | 1,372,191 |
| Other Non-Current Assets | 288,953 | 380,065 | 377,048 | 395,941 | 459,083 |
| TOTAL | $6,441,106 | $6,480,289 | $5,854,194 | $4,032,121 | $4,304,934 |
| Total Assets | $24,945,610 | $24,563,000 | $22,315,660 | $24,379,390 | $24,632,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 62,419 | 59,485 | 58,469 | 42,743 | 41,125 |
| Accounts payable and accrued liabilities | 467,326 | 572,368 | 467,543 | 461,732 | 838,555 |
| Other current liabilities | 2,060,771 | 1,464,976 | 1,084,894 | 2,221,010 | 1,494,246 |
| TOTAL | $2,597,880 | $2,101,028 | $1,616,596 | $2,730,355 | $2,773,741 |
| Non-Current Liabilities | |||||
| Long Term Debt | 224,429 | 246,565 | 250,206 | 232,327 | 226,848 |
| Other Non-Current Liabilities | 496,899 | 1,176,067 | 463,224 | 366,074 | 571,902 |
| TOTAL | $749,616 | $1,454,986 | $759,890 | $644,282 | $840,314 |
| Total Liabilities | $3,347,496 | $3,556,014 | $2,376,485 | $3,374,637 | $3,614,055 |
| Shareholders' Equity | |||||
| Common Shares | 290,589 | 282,211 | 261,900 | 269,010 | 273,361 |
| Retained earnings | 21,352,180 | N/A | 19,681,700 | 20,665,950 | N/A |
| Other shareholders' equity | -1,734,295 | -1,679,041 | -1,520,266 | -1,434,635 | -1,469,631 |
| TOTAL | $21,598,120 | $21,006,990 | $19,939,170 | $21,004,750 | $21,018,300 |
| Total Liabilities And Equity | $24,945,616 | $24,563,004 | $22,315,655 | $24,379,387 | $24,632,355 |